Vitalea Science provides services to researchers and clinicians who require extremely sensitive detection of 14C-labeled drugs or other chemicals for biomedical research using the Accelerator Mass Spectrometer (AMS). We strive to develop long-term relationships with our clientele by providing advanced clinical drug develop­ment solutions. We uphold this philosophy through a focused emphasis on integrity, teamwork, and exceptional science and technology. Some of the services we provide are:

  • Traditional radioanalysis
  • Validated UPLC for rapid profiling
  • An independent quality assurance unit
  • A strong scientific team with decades of experience in drug metabolism
  • An in-house IT department
  • 21CFR compliance
  • The next generation of AMS technology, BioMICADASTM

AMS achieves low attomolar (10-18) detection limits with less than 3% measurement imprecision. This high sensitivity affords many possibilities for biomedical research. Inclusive in these possibilities are the concept of microdosing where subtoxic quantities are tested in man (first-In-Man or Phase-0 studies).

Our team has been at the forefront of developing front-end chemistries for the efficient and reliable detection of the labeled compound in most any matrix. We understand the intricacies of non-standard problems, and when you use Vitalea, you have the support of some of the most experienced AMS researchers in the world.

top of page